Adverse effects have included stomatitis, nausea, vomiting, fever, rhinorrhea, drowsiness, clamminess, chest tightness, and bronchoconstriction
Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of 1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat
Contact your GP if you experience: No improvement after 46 weeks of treatment : Whilst neurological symptoms may take longer to resolve, you should notice some improvement in energy levels or general wellbeing within this timeframe
Hospitals play a critical role in diagnosis, treatment initiation, patient monitoring, and management of complex metabolic disorders